Author Guidelines


1. Submission
2. Aims and Scope
3. Manuscript Categories and Requirements
4. Preparing the Submission
5. Editorial Policies and Ethical Considerations
6. Author Licensing
7. Publication Process After Acceptance
8. Post Publication
9. Editorial Office Contact Details


Authors should kindly note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium.

New submissions should be made via the Research Exchange submission portal Should your manuscript proceed to the revision stage, you will be directed to make your revisions via the same submission portal. You may check the status of your submission at anytime by logging on to and clicking the “My Submissions” button. For technical help with the submission system, please review our FAQs or contact [email protected].

IMPORTANT: Please check whether you already have an account in the system before trying to create a new one. If you have reviewed or authored for the journal in the past year it is likely that you will have created an account.

Free Format submission 

Pediatric Dermatology now offers Free Format submission for a simplified and streamlined submission process.  

Before you submit, you will need: 

  • Your manuscript: this should be an editable file including text, figures, and tables, or separate files—whichever you prefer. All required sections should be contained in your manuscript, including abstract, introduction, methods, results, and conclusions. Figures and tables should have legends. Figures should be uploaded in the highest resolution possible. If the figures are not of sufficiently high quality your manuscript may be delayed. References may be submitted in any style or format, as long as it is consistent throughout the manuscript. Supporting information should be submitted in separate files. If the manuscript, figures or tables are difficult for you to read, they will also be difficult for the editors and reviewers, and the editorial office will send it back to you for revision. Your manuscript may also be sent back to you for revision if the quality of English language is poor.
  • An ORCID ID, freely available at (Why is this important? Your article, if accepted and published, will be attached to your ORCID profile. Institutions and funders are increasingly requiring authors to have ORCID IDs.)
  • The title page of the manuscript, including:
    • Your co-author details, including affiliation and email address. (Why is this important? We need to keep all co-authors informed of the outcome of the peer review process.)
    • Statements relating to our ethics and integrity policies, which may include any of the following (Why are these important? We need to uphold rigorous ethical standards for the research we consider for publication):
      • data availability statement
      • funding statement
      • conflict of interest disclosure
      • ethics approval statement
      • patient consent statement
      • permission to reproduce material from other sources
      • clinical trial registration

Data protection

By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at

Data Sharing and Data Availability

This journal expects data sharing. Review Wiley’s Data Sharing policy where you will be able to see and select the data availability statement that is right for your submission.

Preprint policy

Please find the Wiley preprint policy here.

This journal accepts articles previously published on preprint servers.

Pediatric Dermatology will consider for review articles previously available as preprints. Authors may also post the submitted version of a manuscript to a preprint server at any time. Authors are requested to update any pre-publication versions with a link to the final published article.

For help with submissions, please contact: [email protected]


The journal provides cutting edge, international information focusing on diagnosis and treatment plus reports of interesting and unusual diseases reported through our Original Articles, State of the Art Reviews, Pediatric Procedural Dermatology, Case Reports and Clinical Letters sections.



Clinical or epidemiologic studies, meta-analyses/systematic reviews, or case series (e.g. five or more patients with novel observations). The material should be presented as concisely as possible. Reports of clinical trials should adhere to the tenets of the CONSORT statement (JAMA 1996; 276: 637-639).

Abstract: Structured, not exceeding 250 words, organized into the following sections: Background/Objectives, Methods, Results, Conclusions.

Word Limit: 2,000 words excluding abstract and references

Table/Figure Limit: 5 figures or tables

Reference Limit: 25 references (exceptions for meta-analyses/systematic reviews)

Text Body: Structured: Introduction, Materials and Methods, Results and Discussion.

Note: if you are submitting a PEDRA Original Article, please state that in your cover letter.


Clinical or epidemiologic studies, surveys or case series (e.g. five or more patients with novel observations) requiring limited. The material should be presented as concisely as possible. Reports of clinical trials should adhere to the tenets of the CONSORT statement (JAMA 1996; 276: 637-639).

Survey studies should include survey instrument as a supplemental file and must include theresponse rate.

Abstract: Four-sentence unstructured abstract not exceeding 250 words

Word Limit: 750 words

Table/Figure Limit: 2 figures or tables

Reference Limit: 10 references

Note: if you are submitting a PEDRA Research In Brief article, please state that in your cover letter.


Concise, up-to-date reviews which document and synthesize current information on specific topic areas such as new insights into a disease or group of diseases, therapeutics or new developments. Questions, including queries about whether a specific review would be of interest to the readership, can be addressed to Associate Editor, Dawn Davis, MD ([email protected]). 

Abstract: unstructured format, not exceeding 250 words

Word Limit: 3,000 words

Reference Limit: 30 references 


Submissions relating to the broad area of procedural dermatology, including excisional surgery, laser surgery, or any of the physical modalities such as cryotherapy, photodynamic therapy; surgical instruments or new technology relating to procedural pediatric dermatology. Vignettes of practice pearls related to procedures would fall into this section as well. Submissions describing a specific technique should describe the technique in a step-by-step process, to communicate to readers the technique as clearly as possible (as if it part of an instruction manual). Questions may be addressed to either of the Editors-in-Chief or to Section Editor, Andrew Krakowski, MD ([email protected]).

Word Limit: 1,000 words excluding abstract and references

Reference Limit: 10 references

Table/Figure Limit: 2 or 3 illustrations

Text Body: Can be in the same format as full-length Original Article, Case Report, Research in Brief, or Clinical Letters.

•The journal has the ability to publish streaming video online as an adjunct to a printed publication and encourages consultation with the section editors if the submission of an accompanying video adds to the value of the printed publication. Video clips should be downloaded as the last file(s) at the time of manuscript submission and marked as supplementary material. Submit as MPG/MPEG or AVI. Clips must be created with commonly-used codecs, and the codec used should be noted in the supplementary material legend. Video files should be tested for playback before submission, preferably on computers not used for its creation, to check for any compatibility issues. Wiley will not host codec files, or be responsible for supporting video supplementary material where the codec used is non-standard. The video clip file name(s) should refer to the corresponding Figure number and must be supplied with a legend at the end of the References.


Extended essays or commentaries providing an opportunity to express personal views and opinions that are meant to enlighten, entertain, and educate readers, and can include articles about medical history, ethics, literature or the arts related to pediatric dermatology. Patient perspectives are also encouraged. Questions on whether a potential submission is appropriate for this section can be addressed to the Editors-in-Chief, or the Section Editors, Lucinda Kohn, MD, MHS ([email protected]) or Neil Prose, MD ([email protected]).

Word Limit: 1500 words

Reference Limit: 15 references


Case series and case reports of unusual interest warranting a more comprehensive description than Clinical Letters. If 5 or more patients are reported, this should generally be submitted as an Original Article.

Abstract: 4 sentences, should describe the case findings and significance of the report

Word Limit: 1,500 words

Table/Figure Limit: 5 illustrations or tables

Figure Guidelines:  Photomicrographs and illustrations must be sharply focused, with excellent color balance.

Reference Limit: 25 references


Short case reports or brief observations.

Author Limit: 6 authors

Abstract: 4 sentences, should describe the case findings and significance of the report

Word Limit: 500 words (excluding abstract and references)

Table/Figure Limit: 2 figures

Figure Guidelines:  Photomicrographs and illustrations must be sharply focused, with excellent color balance.

Reference Limit: 5 references


High-quality clinical images and a brief clinical history as a diagnostic unknown, with the diagnosis and key case features succinctly discussed on a separate print page. Note this section is not sent out for peer reviewed but is reviewed by the Section Editor and Editor-in-Chief.

Author Limit: 5 authors

Abstract: None

Word Limit: 850 words (excluding acknowleedgments, figures, references and online-only material). The case report should be limited to 250 words or less

Figure Limit: 4 figures

Figure Guidelines: No figure legends are used in this section. Descriptions of certain figures needing explanation (such as radiographs or histopathology) should be included within the body of the article. Photomicrographs and illustrations must be sharply focused, with excellent color balance. Figures should ideally be presented in the same aspect ratio.

Reference Limit: 10 references

Text Body: The submission should be divided into 2 major sections on separate text pages:

  • A case presentation, ending with a question, "What is the Diagnosis?"
  • Figures, including histopathology, which accompany the case report will precede “What is the Diagnosis?”, while any explanatory figures that “give away” the diagnosis should follow and will appear on the back page.
  • A page break should follow “What is the diagnosis?”
  • The diagnosis should be provided, “Diagnosis:” followed by “Discussion”


Invited by the Editors-in-Chief to accompany an article of special interest or can be submitted independently, preferably after corresponding with the Editors-in-Chief on a subject of special interest to our readership.

Word Limit: 500 words

Table/Figure Limit: 1 figure or table

Reference Limit: 5 references


Provides a forum for response to articles previously published in the journal. Should contain specific references and be received within 4 months of the article’s publication.

Word Limit: 500 words

Table/Figure Limit: 1 figure or table

Reference Limit: 5 references


Cover Letters

Cover letters are not mandatory; however, they may be supplied at the author’s discretion.

Main Text File

Manuscripts can be uploaded either as a single document (containing the main text, tables and figures), or with figures and tables provided as separate files. Should your manuscript reach revision stage, figures and tables must be provided as separate files. The main manuscript file can be submitted in Microsoft Word (.doc or .docx) or LaTex (.tex) format.

If submitting your manuscript file in LaTex format via Research Exchange, select the file designation “Main Document – LaTeX .tex File” on upload. When submitting a LaTex Main Document, you must also provide a PDF version of the manuscript for Peer Review. Please upload this file as “Main Document - LaTeX PDF.” All supporting files that are referred to in the LaTex Main Document should be uploaded as a “LaTeX Supplementary File.”  

LaTex Guidelines for Post-Acceptance: 

Please check that you have supplied the following files for typesetting post-acceptance:  

  • PDF of the finalized source manuscript files compiled without any errors. 
  • The LaTeX source code files (text, figure captions, and tables, preferably in a single file), BibTex files (if used), any associated packages/files along with all other files needed for compiling without any errors. This is particularly important if authors have used any LaTeX style or class files, bibliography files (.bbl, .bst. .blg) or packages apart from those used in the NJD LaTex Template class file.  
  • Electronic graphics files for the illustrations in Encapsulated PostScript (EPS), PDFor TIFF format. Authors are requested not to create figures using LaTeX codes. 

Your main document file should include: 

  1. A short informative title containing the major key words. The title should not contain abbreviations (see Wiley's best practice SEO tips);
  2. The full names of the authors;
  3. The author's institutional affiliations where the work was conducted, with a footnote for the author’s present address if different from where the work was conducted;
  4. Keywords;
  5. Word, figure and reference count;
  6. Acknowledgments;
  7. Conflict of Interest statement;
  8. Consent statement;
  9. Abstract;
  10. Main text;
  11. References;
  12. Tables (each table complete with title and footnotes);
  13. Figure legends;
  14. Appendices (if relevant).

Figures and supporting information should be supplied as separate files.


Please provide five keywords. Keywords should be taken from those recommended by the US National Library of Medicine's Medical Subject Headings (MeSH) browser list at


Please refer to the journal’s authorship policy the Editorial Policies and Ethical Considerations section for details on eligibility for author listing.

Original Articles only: a statement listing the contribution of each author to the manuscript should be included


Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section. Financial and material support should also be mentioned. Thanks to anonymous reviewers are not appropriate.

Conflict of Interest Statement

Authors will be asked to provide a conflict of interest statement during the submission process. For details on what to include in this section, see the section ‘Conflict of Interest’ in the Editorial Policies and Ethical Considerations section below. Submitting authors should ensure they liaise with all co-authors to confirm agreement with the final statement. If no conflicts of interest relevant to the content of the submission are present, please state "no conflict of interest".

Consent Statement

Notice of informed consent and releases from the parent(s)/guardian(s) and/or the patient to publish photographs of recognizable persons should be submitted with the manuscript. Please note that "black-out" bars over the patient's eyes do NOT adequately protect against facial recognition and photo consent is still needed, even if these "black-out" bars are used.


Except Correspondence and Photoquiz, all submissions must include an abstract, clearly labeled as such, preceding the Introduction section of the manuscript. Abstracts are limited to 4 sentences, except for Original Articles. All Original Articles must have a structured abstract, not exceeding 250 words, and organized into the following sections: Background/Objectives, Methods, Results, Conclusions.

Main Text 

  • For experimental investigations of human or animal subjects, state in the 'Methods" section that an appropriate institutional review board approved the project, and that informed consent was appropriately obtained. For more information, see the ‘Editorial Policies and Ethical Considerations’ section below.
  • Footnotes to the text are not allowed and any such material should be incorporated into the text as parenthetical matter.

Methods and Materials

If a method or tool is introduced in the study, including software, questionnaires, and scales, the author should state the license this is available under and any requirement for permission for use. If an existing method or tool is used in the research, the authors are responsible for checking the license and obtaining the permission. If permission was required, a statement confirming permission should be included in the Methods and Materials section.


All references should be numbered consecutively in order of appearance and should be as complete as possible. In text citations should cite references in consecutive order.

This journal uses AMA reference style; as the journal offers Free Format submission, however, this is for information only and you do not need to format the references in your article. This will instead be taken care of by the typesetter.



Tables should be self-contained and complement, not duplicate, information contained in the text. They should be editable, not pasted as images (jpg, tiff, etc). Legends should be concise but comprehensive – the table, legend, and footnotes must be understandable without reference to the text. All abbreviations must be defined in footnotes.

Figure Legends

Legends should be concise but comprehensive – the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement.


All supplementary figures, patient photos, photomicrographs, and illustrations must be sharply focused, with excellent colour balance and ideally submitted as separately numbered TIFF, PNG, or JPG files in as high a resolution as possible.

Photo montages should be submitted as separate images labelled, for example, Figure 1A, Figure 1B, etc, and not include more than four images.

Composite photos should not be submitted. Figures beyond the figure limit should be submitted as supplementary figures.

Click here for detailed guidelines on preparing figures.

It is preferable that line figures (e.g. graphs and charts) are supplied in black and white so that they are legible if printed by a reader in black and white. 

Additional Files


Appendices will be published after the references.

Supporting Information

Supporting information is information that is not essential to the article, but provides greater depth and background. It is hosted online and appears without editing or typesetting. It may include tables, figures, videos, datasets, etc.

Click here for Wiley’s FAQs on supporting information.

Note: if data, scripts, or other artefacts used to generate the analyses presented in the paper are available via a publicly available data repository, authors should include a reference to the location of the material within their paper.

General Style Points

The following points provide general advice on formatting and style.

  • Abbreviations: In general, terms should not be abbreviated unless they are used repeatedly and the abbreviation is helpful to the reader. Initially, use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation only.
  • Originality: Claims of being the first case report of its kind should be avoided unless a detailed search methodology is included. Please include rationale for claim and search methodology in the letter to the editor.
  • Units of measurement: Measurements should be given in SI or SI-derived units. Visit the Bureau International des Poids et Mesures (BIPM) website for more information about SI units.
  • Trade Names: Chemical substances should be referred to by the generic name only. Trade names should not be used. Drugs should be referred to by their generic names. If proprietary drugs have been used in the study, refer to these by their generic name, mentioning the proprietary name and the name and location of the manufacturer in parentheses.


Methods should be referenced. Two-tailed significance tests should be used unless explicitly stated. Controls should be described as completely as experimental subjects. Measures of location should be accompanied by measures of variability (e.g. mean and confidence intervals) as well as conventional probability values. Clinical trial reports should include the power of the study design. P values should be consistently presented.

Wiley Author Resources

Manuscript Preparation Tips: Wiley has a range of resources for authors preparing manuscripts for submission available here. In particular, authors may benefit from referring to Wiley’s best practice tips on Writing for Search Engine Optimization.

Article Preparation Support: Wiley Editing Services offers expert help with English Language Editing, as well as translation, manuscript formatting, figure illustration, figure formatting, and graphical abstract design – so you can submit your manuscript with confidence.
Also, check out our resources for Preparing Your Article for general guidance about writing and preparing your manuscript.

Video Abstracts: A video abstract can be a quick way to make the message of your research accessible to a much larger audience. Wiley and its partner Research Square offer a service of professionally produced video abstracts, available to authors of articles accepted in this journal. You can learn more about it by clicking here. If you have any questions, please direct them to [email protected]. This is a paid-for service.

Guidelines for Cover Submissions: If you would like to send suggestions for artwork related to your manuscript to be considered to appear on the cover of the journal, please follow these general guidelines.


Peer Review and Acceptance

This journal offers single blind peer review (except for PhotoQuiz as noted above).

The acceptance criteria for all papers are the quality and originality of the research and its significance to journal readership. Papers will only be sent to review if the Editor-in-Chief determines that the paper meets the appropriate quality and relevance requirements. The Editors retain the usual right to modify the style and length of a contribution (major changes being agreed upon with the corresponding author) and to decide the time of publication.

Wiley's policy on the confidentiality of the review process is available here.

Human Studies and Subjects

For manuscripts reporting medical studies that involve human participants, a statement identifying the ethics committee that approved the study and confirmation that the study conforms to recognized standards is required, for example: Declaration of Helsinki; US Federal Policy for the Protection of Human Subjects; or European Medicines Agency Guidelines for Good Clinical Practice. It should also state clearly in the text that all persons gave their informed consent prior to their inclusion in the study.

Patient anonymity should be preserved. Photographs need to be cropped sufficiently to prevent human subjects being recognized (or an eye bar should be used). Images and information from individual participants will only be published where the authors have obtained the individual's free prior informed consent. Authors do not need to provide a copy of the consent form to the publisher; however, in signing the author license to publish, authors are required to confirm that consent has been obtained. Wiley has a standard patient consent form available for use. 

Animal Studies

A statement indicating that the protocol and procedures employed were ethically reviewed and approved, as well as the name of the body giving approval, must be included in the Methods section of the manuscript. Authors are encouraged to adhere to animal research reporting standards, for example the ARRIVE guidelines for reporting study design and statistical analysis; experimental procedures; experimental animals and housing and husbandry. Authors should also state whether experiments were performed in accordance with relevant institutional and national guidelines for the care and use of laboratory animals:

• US authors should cite compliance with the US National Research Council's Guide for the Care and Use of Laboratory Animals, the US Public Health Service's Policy on Humane Care and Use of Laboratory Animals, and Guide for the Care and Use of Laboratory Animals.
• UK authors should conform to UK legislation under the Animals (Scientific Procedures) Act 1986 Amendment Regulations (SI 2012/3039).
• European authors outside the UK should conform to Directive 2010/63/EU.

Clinical Trial Registration

The journal requires that clinical trials are prospectively registered in a publicly accessible database and clinical trial registration numbers should be included in all papers that report their results. Authors are asked to include the name of the trial register and the clinical trial registration number at the end of the abstract. If the trial is not registered, or was registered retrospectively, the reasons for this should be explained.

Research Reporting Guidelines

Accurate and complete reporting enables readers to fully appraise research, replicate it, and use it. Authors are encouraged to adhere to recognised research reporting standards. The EQUATOR Network collects more than 370 reporting guidelines for many study types, including for:

Randomized trials : CONSORT
Observational studies : STROBE
Systematic reviews : PRISMA
Case reports : CARE
Qualitative research : SRQR
Diagnostic / prognostic studies : STARD
Quality improvement studies: SQUIRE
Economic evaluations: CHEERS
Animal pre-clinical studies: ARRIVE
Study protocols : SPIRIT
Clinical practice guidelines : AGREE

We also encourage authors to refer to and follow guidelines from:

Future of Research Communications and e-Scholarship (FORCE11)
National Research Council's Institute for Laboratory Animal Research guidelines
The Gold Standard Publication Checklist from Hooijmans and colleagues
Minimum Information Guidelines from Diverse Bioscience Communities (MIBBI) website
FAIRsharing website

Species Names

Upon its first use in the title, abstract, and text, the common name of a species should be followed by the scientific name (genus, species, and authority) in parentheses. For well-known species, however, scientific names may be omitted from article titles. If no common name exists in English, only the scientific name should be used.

Genetic Nomenclature

Sequence variants should be described in the text and tables using both DNA and protein designations whenever appropriate. Sequence variant nomenclature must follow the current HGVS guidelines; see, where examples of acceptable nomenclature are provided.

Sequence Data

Nucleotide sequence data can be submitted in electronic form to any of the three major collaborative databases: DDBJ, EMBL, or GenBank. It is only necessary to submit to one database as data are exchanged between DDBJ, EMBL, and GenBank on a daily basis. The suggested wording for referring to accession-number information is: ‘These sequence data have been submitted to the DDBJ/EMBL/GenBank databases under accession number U12345’. Addresses are as follows:

Proteins sequence data should be submitted to either of the following repositories:

Conflict of Interest

The journal requires that all authors disclose any potential sources of conflict of interest. Any interest or relationship, financial or otherwise that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript. Potential sources of conflict of interest include, but are not limited to: patent or stock ownership, membership of a company board of directors, membership of an advisory board or committee for a company, and consultancy for or receipt of speaker's fees from a company. The existence of a conflict of interest does not preclude publication. If the authors have no conflict of interest to declare, they must also state this at submission. It is the responsibility of the corresponding author to review this policy with all authors and collectively to disclose with the submission ALL pertinent commercial and other relationships.


Authors should list all funding sources in the Acknowledgments section. Authors are responsible for the accuracy of their funder designation. If in doubt, please check the Open Funder Registry for the correct nomenclature:


The list of authors should accurately illustrate who contributed to the work and how. All those listed as authors should qualify for authorship according to the following criteria:

  1. Have made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; and
  2. Been involved in drafting the manuscript or revising it critically for important intellectual content; and
  3. Given final approval of the version to be published. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content; and
  4. Agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section (for example, to recognize contributions from people who provided technical help, collation of data, writing assistance, acquisition of funding, or a department chairperson who provided general support). Prior to submitting the article all authors should agree on the order in which their names will be listed in the manuscript.

Additional Authorship Options. Joint first or senior authorship: In the case of joint first authorship, a footnote should be added to the author listing, e.g. ‘X and Y should be considered joint first author’ or ‘X and Y should be considered joint senior author.’

Data Sharing and Data Accessibility

Please review Wiley’s policy here. This journal encourages peer review data sharing.

The journal encourages authors to share the data and other artefacts supporting the results in the paper by archiving it in an appropriate public repository. Authors should include a data accessibility statement, including a link to the repository they have used, in order that this statement can be published alongside their paper.

All accepted manuscripts may elect to publish a data availability statement to confirm the presence or absence of shared data. If you have shared data, this statement will describe how the data can be accessed, and include a persistent identifier (e.g., a DOI for the data, or an accession number) from the repository where you shared the data. Sample statements are available here. If published, statements will be placed in the heading of your manuscript.

Publication Ethics

This journal is a member of the Committee on Publication Ethics (COPE). Note this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read Wiley'sTop 10 Publishing Ethics Tips for Authors here. Wiley’s Publication Ethics Guidelines can be found here.


As part of the journal’s commitment to supporting authors at every step of the publishing process, the journal requires the submitting author (only) to provide an ORCID iD when submitting a manuscript. This takes around 2 minutes to complete. Find more information here.

Wiley’s Author Name Change Policy

In cases where authors wish to change their name following publication, Wiley will update and republish the paper and redeliver the updated metadata to indexing services. Our editorial and production teams will use discretion in recognizing that name changes may be of a sensitive and private nature for various reasons including (but not limited to) alignment with gender identity, or as a result of marriage, divorce, or religious conversion. Accordingly, to protect the author’s privacy, we will not publish a correction notice to the paper, and we will not notify co-authors of the change. Authors should contact the journal’s Editorial Office with their name change request.

Transferable Review: Health Science Reports

This journal works together with Wiley’s Open Access Journal, Health Science Reports to enable rapid publication of good quality research that is unable to be accepted for publication by our journal. Authors may be offered the option of having the paper, along with any related peer reviews, automatically transferred for consideration by the Editor of Health Science Reports. Authors will not need to reformat or rewrite their manuscript at this stage, and publication decisions will be made a short time after the transfer takes place. The Editor of Health Science Reports will accept submissions that report well-conducted research that reaches the standard acceptable for publication. Health Science Reports is a Wiley Open Access journal which is indexed on PubMed/MEDLINE and Scopus. For more information please go to We look forward to your submission.


If your paper is accepted, the author identified as the formal corresponding author will receive an email prompting them to log in to Author Services, where via the Wiley Author Licensing Service (WALS) they will be required to complete a copyright license agreement on behalf of all authors of the paper.

Authors may choose to publish under the terms of the journal’s standard copyright agreement, or open access in hybrid titles under the terms of a Creative Commons License.

General information regarding licensing and copyright is available here. To review the Creative Commons License options offered under open access in hybrid titles , please click here. (Note that certain funders mandate that a particular type of CC license has to be used; to check this please click here.)

Self-Archiving definitions and policies. Note that the journal’s standard copyright agreement allows for self-archiving of different versions of the article under specific conditions. Please click here for more detailed information about self-archiving definitions and policies.

Open Access fees: If you choose to publish using open access in hybrid titles you will be charged a fee. For more information on this journal’s APCs, please see the Open Access page.

Funder Open Access: Please click here for more information on Wiley’s compliance with specific Funder Open Access Policies.


Accepted article received in production

When an accepted article is received by Wiley’s production team, the corresponding author will receive an email asking them to login or register with Wiley Author Services. The author will be asked to sign a publication license at this point.


Once the paper is typeset, the author will receive an email notification with full instructions on how to provide proof corrections.

Please note that the author is responsible for all statements made in their work, including changes made during the editorial process – authors should check proofs carefully. Note that proofs should be returned within 48 hours from receipt of first proof. 

Early View

The journal offers rapid speed to publication via Wiley’s Early View service. Early View (Online Version of Record) articles are published on Wiley Online Library before inclusion in an issue. Note there may be a delay after corrections are received before the article appears online, as Editors also need to review proofs. Once the article is published on Early View, no further changes to the article are possible. The Early View article is fully citable and carries an online publication date and DOI for citations.


Access and sharing

When the article is published online:

  • The author receives an email alert (if requested).
  • The link to the published article can be shared through social media.
  • The author will have free access to the paper (after accepting the Terms & Conditions of use, they can view the article).
  • The corresponding author and co-authors can nominate up to ten colleagues to receive a publication alert and free online access to the article.
  • All articles will be published online. Most articles will be published in print as well; however, some articles (Clinical Letters, Case Report and PhotoQuiz) may be published online only at the discretion of the editors.

Article Promotion Support

Wiley Editing Services offers professional video, design, and writing services to create shareable video abstracts, infographics, conference posters, lay summaries, and research news stories for your research – so you can help your research get the attention it deserves. 

Measuring the Impact of an Article

Wiley also helps authors measure the impact of their research through specialist partnerships with Kudos and Altmetric.

Archiving Services

Portico and CLOCKSS are digital archiving/preservation services we use to ensure that Wiley content will be accessible to customers in the event of a catastrophic event such as Wiley going out of business or the platform not being accessible for a significant period of time. Member libraries participating in these services will be able to access content after such an event. Wiley has licenses with both Portico and CLOCKSS, and all journal content gets delivered to both services as it is published on Wiley Online Library. Depending on their integration mechanisms, and volume loads, there is always a delay between content being delivered and showing as “preserved” in these products.


E-mail: [email protected] 

Author Guidelines updated 6 March 2023